Results 341 to 350 of about 2,206,632 (403)

Biomimetic Organic Nanozyme as Tumor Vaccines for Targeted Suppression of Ammonia‐Induced T Lymphocyte Death to Augment Breast Cancer Immunotherapy

Advanced Science, EarlyView.
The organic nanozyme IR‐IHpd, which has NIR‐PDT and POD‐like activity, is designed for continuous ROS generation. It is co‐encapsulated with CB‐839 and coated with DC membranes to simultaneously target tumors and T cells. Under NIR irradiation, immunogenic cell death is activated. Concurrently, CB‐839 suppresses ammonia‐induced T lymphocyte death (AITD)
Meng Suo, Deyi Yang, Mingpu Yang, Jue Wang, Dingfeng Zhang, Daoming Zhu, Qingyong Xu, Yanni Song   +7 more
wiley   +1 more source

Vaccines and vaccination

, 2010
John D. Grabenstein, Walter L. Straus, Mark B. Feinberg   +2 more
openaire   +1 more source

Substituent‐Based Modulation of Self‐Assembly and Immunogenicity of Amphipathic Peptides

Advanced Science, EarlyView.
This study systematically investigates how positional and subtle changes, such as substituents on the phenyl ring attached to short amphipathic peptides, influence their self‐assembly, fibril morphology, and immunogenic responses. ABSTRACT Self‐assembled peptide‐based biomaterials provide versatile platforms for biomedical uses, featuring customizable ...
Anirban Das, Ushasi Pramanik, Elise M. Brown, Chih‐Yun Liu, Huan Gong, Jonathan Fascetti, Mark Gibson, Samuel Stealey, Silviya P. Zustiak, Cory Berkland, Piyoosh Sharma, Meredith E. Jackrel, Mark A. White, Jai S. Rudra   +13 more
wiley   +1 more source

Vaccine therapy for pediatric high-grade glioma: current landscape, challenges, and future directions. [PDF]

J Neurooncol
Harper SD, Alderete JA, Baisiwala S, Bergsneider BH, Liau LM, Wang AC.   +5 more
europepmc   +1 more source

Opportunities and Challenges of mRNA and VLP Technologies for Pan-Flavivirus Vaccine Development: Focus on Conserved Quaternary Epitope Conformations. [PDF]

Int J Mol Sci
Pinzon Burgos EF, Camacho Ortega S, Atkinson B, Chua JV, Heredia A.   +4 more
europepmc   +1 more source

First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. [PDF]

Euro Surveill
Foster K, Heymer EJ, Campbell H, Wilson E, Baldasera J, Lucidarme J, Clark SA, Bai X, Ahmad S, Borrow R, Ladhani SN.   +10 more
europepmc   +1 more source

Oral β-D-glucan potentiates systemic immune responses to intramuscular foot-and-mouth disease vaccination. [PDF]

Front Vet Sci
Kim HW, Park SH, Ko MK, Shin S, Park JH, Lee MJ.   +5 more
europepmc   +1 more source

Liver Safety Assessment of an Indonesian Hexavalent Vaccine Candidate Through Histopathology and ALT/AST Evaluation in Rats and Rabbits. [PDF]

Vaccines (Basel)
Pratiwi ED, Mawaddah TW, Sadjuri AR, Nugroho DT, Hidayat A, Nidom AN, Ayyuba ZI, Wahyuningsih ES, Santoso KP, Plumeriastuti H, Soeharsono, Indrasari S, Nidom RV, Wijayadikusumah AR, Nidom CA.   +14 more
europepmc   +1 more source

Vaccine, vaccination & personal decision making

The Indian Journal of Medical Research
openaire   +2 more sources